e-Article
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial
Document Type
Article
Author
Chung, Lorinda; Spino, Cathie; McLain, Richard; Johnson, Sindhu R; Denton, Christopher P; Molitor, Jerry A; Steen, Virginia D; Lafyatis, Robert; Simms, Robert W; Kafaja, Suzanne; Frech, Tracy M; Hsu, Vivien; Domsic, Robyn T; Pope, Janet E; Gordon, Jessica K; Mayes, Maureen D; Sandorfi, Nora; Hant, Faye N; Bernstein, Elana J; Chatterjee, Soumya; Castelino, Flavia V; Ajam, Ali; Allanore, Yannick; Matucci-Cerinic, Marco; Whitfield, Michael L; Distler, Oliver; Singer, Ora; Young, Amber; Nagaraja, Vivek; Fox, David A; Furst, Daniel E; Khanna, Dinesh
Source
In The Lancet Rheumatology December 2020 2(12):e743-e753
Subject
Language
ISSN
2665-9913